Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemophilia
Pharma
Europe's CHMP backs Novo's FDA-rejected hemophilia treatment
The European drug reviewers gave a thumbs-up to Novo's FDA-rejected hemophilia treatment, but they turned down PTC Therapeutics' Translarna yet again.
Zoey Becker
Oct 18, 2024 11:27am
FDA approves Pfizer's injected Hympavzi for hemophilia A or B
Oct 11, 2024 4:20pm
BioMarin downsizes gene therapy efforts to focus on 3 markets
Aug 6, 2024 10:34am
Pfizer's hemophilia B gene therapy snags EU approval
Jul 25, 2024 2:40pm
With slow sales, BioMarin weighs Roctavian divestiture
Apr 29, 2024 11:51am
Pfizer charges $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
